Identification of pyroptosis-related genes and long non-coding RNAs signatures in osteosarcoma

被引:0
作者
Jian Zhang
Jianjian Deng
Rui Ding
Jinghong Yuan
Jiahao Liu
Xiaokun Zhao
Tianlong Wu
Jingyu Jia
Xigao Cheng
机构
[1] The Second Affiliated Hospital of Nanchang University,Department of Orthopedics
[2] Institute of Orthopedics of Jiangxi Province,Institute of Minimally Invasive Orthopedics
[3] Nanchang University,undefined
来源
Cancer Cell International | / 22卷
关键词
Osteosarcoma; Pyroptosis; lncRNA; Biomarkers; Prognostic signature;
D O I
暂无
中图分类号
学科分类号
摘要
Osteosarcoma is a highly malignant tumor, with very high disability and fatality rates. However, the overall prognosis is not optimistic. Pyroptosis is a newly discovered cell death modality accompanied by inflammation, which is closely related to varieties of cancers. In this study, the RNA-seq data were downloaded from public databases, the differences in the expression of the pyroptosis-related genes (PRGs) were identified, and the six PRGs signature was established through the univariate and LASSO Cox analysis. The patients were grouped according to the PRGs signature, and the prognosis between the two groups was further compared. In addition, a ten pyroptosis-related lncRNAs (PRLs) prognostic signature was also constructed. Through functional analysis of the differentially expressed genes (DEGs), the immune-related pathways were found to be enriched. The Pearson correlation analysis showed a strong correlation between the pyroptosis-related biomarkers. Finally, we identified a promising biomarker, CHMP4C, which is highly expressed in osteosarcoma. Overexpression of CHMP4C promoted the proliferation, migration and invasion of the osteosarcoma cell. Our results thus provide new evidence for exploring prognostic biomarkers and therapeutic targets of osteosarcoma.
引用
收藏
相关论文
共 413 条
[51]  
Zhang B(2019)Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers Pathol Res Pract 215 843-undefined
[52]  
Liu J(2020)Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation Cell Death Dis 11 41-undefined
[53]  
Liang C(2019)Long noncoding RNA FOXD2-AS1 promotes the malignancy of cervical cancer by sponging microRNA-760 and upregulating hepatoma-derived growth factor Front Pharmacol 10 1700-undefined
[54]  
Hua J(2019)Downregulation of the long non–coding RNA FOXD2–AS1 inhibits cell proliferation, migration and invasion in osteosarcoma Mol Med Rep 20 292-undefined
[55]  
Meng Q(2019)HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21 Biomed Pharmacother 117 109104-undefined
[56]  
Yu X(2021)LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression Eur Rev Med Pharmacol Sci 25 678-undefined
[57]  
Shi S(2021)Development and interpretation of a genomic instability derived lncRNAs based risk signature as a predictor of prognosis for clear cell renal cell carcinoma patients Front Oncol 11 678253-undefined
[58]  
Xia X(2019)The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines Hum Cell 32 334-undefined
[59]  
Wang X(2020)LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9 Eur Rev Med Pharmacol Sci 24 2271-undefined
[60]  
Cheng Z(2021)Deciphering the genomic and lncRNA landscapes of aerobic glycolysis identifies potential therapeutic targets in pancreatic cancer Int J Biol Sci 17 107-undefined